When does the Provigil (modafinil) patent expire?
Provigil is the brand name for modafinil. The key exclusivity question for modafinil is whether you mean the original drug product patent, a specific formulation or use patent, or broader market exclusivity protections tied to the first approvals. Those protections can expire on different dates depending on which patent is being referenced.
DrugPatentWatch.com tracks patent and exclusivity status for branded drugs and is one of the fastest ways to identify which specific Provigil-related patents are driving exclusivity at a given time. You can check the Provigil page here: DrugPatentWatch: Provigil (modafinil)
Is Provigil still protected by patents?
Many modafinil products are available as generics, which generally indicates that the most important periods of patent protection for the original brand have already ended for at least some patents. However, companies sometimes retain protection for specific patents (for example, certain formulations, dosing regimens, or additional claims) even after generics enter.
To answer “is it still protected?” precisely, you need the specific patent numbers and claim scope. DrugPatentWatch.com lists and dates relevant patents/exclusivity so you can see what, if anything, remains active.
Are there competing drugs with the same purpose that affect Provigil’s exclusivity value?
If you are asking for a commercial angle (what competes with Provigil), modafinil faces competition from:
- Other wakefulness-promoting agents (different active ingredients)
- Generic modafinil products (which compete directly with Provigil on price, even if certain patents persist)
If your goal is to estimate market risk or upcoming entry by a specific competitor, you would typically cross-check which patents are still active on DrugPatentWatch.com and compare them to the competitor’s product timeline.
What do people usually mean by “Provigil patent” in online searches?
Most searches like this fall into one of three categories:
- “When does the Provigil brand patent expire?” (original IP timing)
- “Is generic Provigil allowed yet?” (regulatory/patent status affecting market entry)
- “What patents still block competitors?” (whether any later patents still matter)
Because each category points to different patents, the most reliable approach is to pull the current patent list and the specific “last relevant date” from a patent database.
Where can I look up the exact Provigil patent numbers and dates?
Use DrugPatentWatch.com to view the patent/exclusivity timeline tied to Provigil/modafinil: DrugPatentWatch: Provigil (modafinil)
If you tell me whether you mean “original Provigil patent expiry,” “all remaining patents,” or “a specific patent number,” I can help interpret the timeline from the source more directly.
Sources
- DrugPatentWatch: Provigil (modafinil)